Stanley has made over 5 trades of the Menlo Therapeutics stock since 2018, according to the Form 4 filled with the SEC. Most recently Stanley exercised 32,500 units of MNLO stock worth $20,150 on 4 November 2019.
The largest trade Stanley's ever made was exercising 90,000 units of Menlo Therapeutics stock on 15 October 2019 worth over $55,800. On average, Stanley trades about 17,298 units every 49 days since 2018. As of 4 November 2019 Stanley still owns at least 182,500 units of Menlo Therapeutics stock.
You can see the complete history of Stanley Hirsch stock trades at the bottom of the page.
Stanley's mailing address filed with the SEC is Rehovot, Israel.
Over the last 7 years, insiders at Menlo Therapeutics have traded over $3,825,000 worth of Menlo Therapeutics stock and bought 3,655,938 units worth $21,205,011 . The most active insiders traders include Advisors Llcperceptive Life..., Llc Fmr a Albert Cha. On average, Menlo Therapeutics executives and independent directors trade stock every 85 days with the average trade being worth of $572,944. The most recent stock trade was executed by Sharon Barbari on 20 August 2020, trading 75,000 units of MNLO stock currently worth $111,000.
Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Redwood City, CA.
Menlo Therapeutics executives and other stock owners filed with the SEC include: